Eton Pharmaceuticals Enters Asset Purchase Agreement To Acquire Increlex (Mecasermin Injection) From Ipsen; No Terms Disclosed

Benzinga10/03 18:34

Gilead Wins FDA Nod for Liver Disease Drug

Seeking Alpha08/15 02:25

Gilead Exits J&J Royalty Deal for Liver Drug Ahead of Potential FDA Nod

Seeking Alpha08/10 20:13

IPSEN - Buy-back Programme - Art 5 of MAR - Week 30 - 2024

Yahoo Finance07/31 00:00

Ipsen Liver Disease Drugs Endorsed in EU

Seeking Alpha07/26 22:31

Ipsen And Day One Earlier Announced Exclusive Ex U.S. Licensing Agreement To Commercialize Tovorafenib For The Most Common Childhood Brain Tumor

Benzinga07/25 18:10